This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by HORVATH, E. Articles by SINGER, W. Search for Related Content PubMed PubMed Citation Articles by HORVATH, E. Articles by SINGER, W.

A Novel Type of Pituitary Adenoma: Morphological Features and Clinical Correlations

Departments of Pathology (E.H., K.K.) and Medicine (W.S.), St. Michael's Hospital, and the Departments of Neurosurgery (H.S.S.) and Medicine (D.W.K.), Wellesley Hospital, University of Toronto Toronto, Ontario, Canada
The Departments of Pathology (B. W.S.), Endocrinology and Internal Medicine (R.R.), and Neurosurgery (E.R.L.) Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Dr. E. Horvath, Department of Pathology, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8 Canada.

Twenty patients with a novel, frequently aggressive type of pituitary adenoma, termed silent subtype 3 adenoma on the basis of fine structural criteria, are reported. The surgically removed tumors were studied by morphological techniques, and the findings were correlated with clinical and biochemical data. All tumors were macroadenomas, often with parasellar extension. The histologically diffuse tumors frequently exhibited focal immunopositivity for one or more adenohypophysial hormones, although the majority of adenoma cells were negative. The tumors had characteristic electron microscopic features, assuring specific diagnosis and delineating this tumor type as a distinct ultrastructural entity.

The tumors were removed from 9 women and 11 men (median ages, 27 and 41 yr, respectively). In all women, mild to moderate hyperprolactinemia and its sequelae were present from the early phase of the disease, leading to the erroneous diagnosis of prolactinoma. Bromocriptine therapy (3 patients) reduced serum PRL levels to normal, but failed to halt tumor growth. In men, most adenomas were nonfunctioning; 4 men had mild to moderate hyperprolactinemia. Three men had elevated serum GH levels and acromegaly, suggestive of multidirectional differentiation. Although the putative cell type giving rise to silent subtype 3 adenomas is not known, the tumor should be recognized to avoid erroneous diagnosis and inappropriate treatment.

Received August 17, 1987.

This article has been cited by other articles:

				S. N. Saleem, A.-H. M. Said, and D. H. Lee Lesions of the Hypothalamus: MR Imaging Diagnostic Features RadioGraphics, July 1, 2007; 27(4): 1087 - 1108. [Abstract] [Full Text] [PDF]

				W. Saeger, D. K Ludecke, M. Buchfelder, R. Fahlbusch, H.-J. Quabbe, and S. Petersenn Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry Eur. J. Endocrinol., February 1, 2007; 156(2): 203 - 216. [Abstract] [Full Text] [PDF]

				G. A. Kaltsas, P. Nomikos, G. Kontogeorgos, M. Buchfelder, and A. B. Grossman Diagnosis and Management of Pituitary Carcinomas J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3089 - 3099. [Abstract] [Full Text] [PDF]

				J W Ironside Best Practice No 172: Pituitary gland pathology J. Clin. Pathol., August 1, 2003; 56(8): 561 - 568. [Abstract] [Full Text] [PDF]

				S. J. B. Aylwin, J. P. Welch, C. L. Davey, J. F. Geddes, D. F. Wood, G. M. Besser, A. B. Grossman, J. P. Monson, and J. M. Burrin The Relationship between Steroidogenic Factor 1 and DAX-1 Expression and in Vitro Gonadotropin Secretion in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2476 - 2483. [Abstract] [Full Text] [PDF]

				S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]

				S. L. Asa, K. Somers, and S. Ezzat The MEN-1 Gene Is Rarely Down-Regulated in Pituitary Adenomas J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3210 - 3212. [Abstract] [Full Text]